dr. han on the aphinity trial in her2 early-stage breast cancer
Published 4 years ago • 109 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:19
dr. han on the importance of risk stratification in her2 breast cancer
-
2:06
dr. jahanzeb on the aphinity and extenet trials in breast cancer
-
3:30
the aphinity trial in early-stage her2 breast cancer
-
7:30
aphinity trial in her2 breast cancer
-
1:39
dr. crew on the aphinity trial results in her2 breast cancer
-
5:41
what does her2 positive mean
-
2:55
differential long-term benefit of adjuvant tamoxifen in er /her2- premenopausal postmenopausal bc
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
2:27
dr. yardley on the aphinity trial for her2-positive breast cancer
-
1:01
dr. han on the importance of pcr in breast cancer
-
20:25
her2 early-stage breast cancer: peri-operative therapy
-
6:46
early-stage her2 breast cancer: the atempt trial
-
5:51
the aphinity trial
-
5:56
aphinity trial: adjuvant her2-targeted therapy in her2 bc
-
2:31
results of the aphinity trial in her2-positive breast cancer
-
0:53
dr nanda on treatment de-escalation in her2 breast cancer and tnbc
-
1:31
dr. gwin on the mechanism of action of 𝞪-tea in her2-positive metastatic breast cancer
-
0:47
dr. yee on neoadjuvant pertuzumab in her2-positive breast cancer
-
1:07
dr. mitri on neratinib and pertuzumab in her2-amplified breast cancer
-
5:29
adding lapatinib to adjuvant trastuzumab doesn't improve outcomes in her2-positive breast cancer
-
3:15
a close look at tucatinib in her breast cancer
-
0:59
dr. burstein on the results of the apt trial for her2 breast cancer